Sakinah Gray
Internal Medicine · Baldwin Park, CANPI 1578226783
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,828 and has fallen 66.7% since, to $609 in 2025.
Across 136 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$740
- Incyte Corporation$511
- AstraZeneca$452
- Novartis$256
- AVEO Pharmaceuticals, Inc.$200
- Takeda Pharmaceuticals U.S.A., Inc.$126
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,00891%
- Education$3059%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 37 | $740 |
| Incyte Corporation | 17 | $511 |
| AstraZeneca(2 entities) | 16 | $452 |
| Novartis | 15 | $256 |
| AVEO Pharmaceuticals, Inc. | 4 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $126 |
| Sanofi | 4 | $109 |
| Pfizer | 4 | $90 |
| AbbVie | 3 | $77 |
| Bayer | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Legend Biotech USA Inc. | 2 | $60 |
| Lilly USA, LLC | 2 | $58 |
| Eisai Inc. | 2 | $50 |
| Merck | 2 | $49 |
| Sobi, Inc | 2 | $48 |
| Agios Pharmaceuticals, Inc. | 2 | $47 |
| Karyopharm Therapeutics Inc. | 2 | $40 |
| GSK | 2 | $38 |
| Array Biopharma Inc | 2 | $35 |
| Beigene USA, Inc. | 1 | $28 |
| Gilead | 1 | $27 |
| Puma Biotechnology, Inc. | 1 | $27 |
| Springworks Therapeutics, Inc. | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $23 |
| Coherus Oncology, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Immunogen, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$125
How this compares
$3,313 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Baldwin Park
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.